Piperazine ferulate attenuates high glucose‑induced mesangial cell injury via the regulation of p66<sup>Shc</sup>

Yang,Yong-Yu; Deng,Rong-Rong; Chen,Zhuo; Yao,Liang-Yuan; Yang,Xi-Ding; Xiang,Da-Xiong

doi:10.3892/mmr.2021.12013

Piperazine ferulate attenuates high glucose‑induced mesangial cell injury via the regulation of p66^Shc

Authors:
- Yong-Yu Yang
- Rong-Rong Deng
- Zhuo Chen
- Liang-Yuan Yao
- Xi-Ding Yang
- Da-Xiong Xiang
View Affiliations

Affiliations: Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China, School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, P.R. China, Department of Geriatrics, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China, Hunan Provincial Engineering Research Central of Translational Medical and Innovative Drug, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China
Published online on: March 16, 2021 https://doi.org/10.3892/mmr.2021.12013
Article Number: 374
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diabetic nephropathy (DN) is a severe microvascular complication of diabetes. Hyperglycemia‑induced glomerular mesangial cells injury is associated with microvascular damage, which is an important step in the development of DN. Piperazine ferulate (PF) has been reported to exert protective effects against the progression of DN. However, whether PF prevents high glucose (HG)‑induced mesangial cell injury remains unknown. The aim of the present study was to investigate the effects of PF on HG‑induced mesangial cell injury and to elucidate the underlying mechanisms. Protein and mRNA expression levels were determined via western blot analysis and reverse transcription‑quantitative PCR, respectively. IL‑6 and TNF‑α levels were measured using ELISA. Reactive oxygen species levels and NF‑κB p65 nuclear translation were determined via immunofluorescence analysis. Apoptosis was assessed by measuring lactate dehydrogenase (LDH) release, as well as using MTT and flow cytometric assays. The mitochondrial membrane potential of mesangial cells was determined using the JC‑1 kit. The results revealed that LDH release were increased; however, cell viability and mitochondrial membrane potential were decreased in the HG group compared with the control group. These changes were inhibited after the mesangial cells were treated with PF. Moreover, PF significantly inhibited the HG‑induced production of inflammatory cytokines and the activation of NF‑κB in mesangial cells. PF also attenuated the HG‑induced upregulation of the expression levels of fibronectin and collagen 4A1. Furthermore, the overexpression of p66^{Src homology/collagen (Shc)} abolished the protective effect of PF on HG‑induced mesangial cell injury. In vivo experiments revealed that PF inhibited the activation of inflammatory signaling pathways, glomerular cell apoptosis and mesangial matrix expansion in diabetic mice. Collectively, the present findings demonstrated that PF attenuated HG‑induced mesangial cells injury by inhibiting p66^Shc.

View Figures

View References

1	Mou X, Chenv JW, Zhou DY, Liu K, Chen LJ, Zhou D and Hu YB: A novel identified circular RNA, circ_0000491, aggravates the extracellular matrix of diabetic nephropathy glomerular mesangial cells through suppressing miR101b by targeting TGFbetaRI. Mol Med Rep. 22:3785–3794. 2020.PubMed/NCBI
2	Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW and Malanda B: IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 138:271–281. 2018. View Article : Google Scholar : PubMed/NCBI
3	Yang X, Hu C, Wang S and Chen Q: Clinical efficacy and safety of Chinese herbal medicine for the treatment of patients with early diabetic nephropathy: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 99:e206782020. View Article : Google Scholar : PubMed/NCBI
4	Jia Q, Yang R, Liu XF, Ma SF and Wang L: Genistein attenuates renal fibrosis in streptozotocin-induced diabetic rats. Mol Med Rep. 19:423–431. 2019.PubMed/NCBI
5	Zhang J, Dong XJ, Ding MR, You CY, Lin X, Wang Y, Wu MJ, Xu GF and Wang GD: Resveratrol decreases high glucose induced apoptosis in renal tubular cells via suppressing endoplasmic reticulum stress. Mol Med Rep. 22:4367–4375. 2020.PubMed/NCBI
6	Dou L and Jourde-Chiche N: Endothelial toxicity of high glucose and its by-products in diabetic kidney disease. Toxins (Basel). 11:5782019. View Article : Google Scholar
7	Tung CW, Hsu YC, Shih YH, Chang PJ and Lin CL: Glomerular mesangial cell and podocyte injuries in diabetic nephropathy. Nephrology (Carlton). 23 (Suppl 4):S32–S37. 2018. View Article : Google Scholar
8	Chen X, Yang Y, Liu C, Chen Z and Wang D: Astragaloside IV ameliorates high glucoseinduced renal tubular epithelial mesenchymal transition by blocking mTORC1/p70S6K signaling in HK2 cells. Int J Mol Med. 43:709–716. 2019.PubMed/NCBI
9	Maezawa Y, Cina D and Quaggin SE: Glomerular cell biology. Chapter 22. The Kidney. 5th edition. Alpern RJ, Moe OW and Caplan M: San Diego: Academic Press; pp. 721–755. 2013
10	Mishra R, Emancipator SN, Kern T and Simonson MS: High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney Int. 67:82–93. 2005. View Article : Google Scholar : PubMed/NCBI
11	Tsai YC, Kuo MC, Hung WW, Wu LY, Wu PH, Chang WA, Kuo PL and Hsu YL: High glucose induces mesangial cell apoptosis through miR-15b-5p and promotes diabetic nephropathy by extracellular vesicle delivery. Mol Ther. 28:963–974. 2020. View Article : Google Scholar : PubMed/NCBI
12	Ostergaard JA, Cooper ME and Jandeleit-Dahm KAM: Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease. J Nephrol. 33:917–929. 2020. View Article : Google Scholar : PubMed/NCBI
13	Di Lisa F, Giorgio M, Ferdinandy P and Schulz R: New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases. Br J Pharmacol. 174:1690–1703. 2017. View Article : Google Scholar : PubMed/NCBI
14	Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, et al: Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell. 122:221–233. 2005. View Article : Google Scholar : PubMed/NCBI
15	Clark JS, Faisal A, Baliga R, Nagamine Y and Arany I: Cisplatin induces apoptosis through the ERK-p66shc pathway in renal proximal tubule cells. Cancer Lett. 297:165–170. 2010. View Article : Google Scholar : PubMed/NCBI
16	Miller B, Palygin O, Rufanova VA, Chong A, Lazar J, Jacob HJ, Mattson D, Roman RJ, Williams JM, Cowley AWJr, et al: p66Shc regulates renal vascular tone in hypertension-induced nephropathy. J Clin Invest. 126:2533–2546. 2016. View Article : Google Scholar : PubMed/NCBI
17	Menini S, Amadio L, Oddi G, Ricci C, Pesce C, Pugliese F, Giorgio M, Migliaccio E, Pelicci P, Iacobini C and Pugliese G: Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress. Diabetes. 55:1642–1650. 2006. View Article : Google Scholar : PubMed/NCBI
18	Zhan M, Usman I, Yu J, Ruan L, Bian X, Yang J, Yang S, Sun L and Kanwar YS: Perturbations in mitochondrial dynamics by p66Shc lead to renal tubular oxidative injury in human diabetic nephropathy. Clin Sci (Lond). 132:1297–1314. 2018. View Article : Google Scholar : PubMed/NCBI
19	Jiang W, Xiao T, Han W, Xiong J, He T, Liu Y, Huang Y, Yang K, Bi X, Xu X, et al: Klotho inhibits PKCalpha/p66SHC-mediated podocyte injury in diabetic nephropathy. Mol Cell Endocrinol. 494:1104902019. View Article : Google Scholar : PubMed/NCBI
20	Li D, Li B, Peng LX, Liu R and Zeng N: Therapeutic efficacy of piperazine ferulate combined with irbesartan in diabetic nephropathy: A Systematic review and meta-analysis. Clin Ther. 42:2196–2212. 2020. View Article : Google Scholar : PubMed/NCBI
21	Liu Z, Pan J, Sun C, Zhou J and Li NA: Clinical effects of perazine ferulate tablets combined with eucalyptol limonene pinene enteric soft capsules for treatment of children with IgA nephropathy. Exp Ther Med. 12:169–172. 2016. View Article : Google Scholar : PubMed/NCBI
22	Zheng L, Chen S, Wang F, Huang S, Liu X, Yang X, Zhou H, Zhao GP, Luo M, Li S and Chen J: Distinct responses of gut microbiota to Jian-Pi-Yi-Shen decoction are associated with improved clinical outcomes in 5/6 nephrectomized rats. Front Pharmacol. 11:6042020. View Article : Google Scholar : PubMed/NCBI
23	Jianzhi S, Qizeng W, Bin L, Wenhui L, Yunpeng C, Chenrong F, Lin Z and Huiting C: Piperazine ferulate exerts antihypertensive effect and improves endothelial function in vitro and in vivo via the activation of endothelial nitric oxide synthase. Cell Mol Biol (Noisy-le-grand). 65:119–124. 2019. View Article : Google Scholar : PubMed/NCBI
24	Yang YY, Shi LX, Li JH, Yao LY and Xiang DX: Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase. Mol Med Rep. 19:2245–2253. 2019.PubMed/NCBI
25	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
26	Wong YH and Abdul Kadir H: Induction of mitochondria-mediated apoptosis in Ca Ski human cervical cancer cells triggered by mollic acid arabinoside isolated from leea indica. Evid Based Complement Alternat Med. 2012:6847402012. View Article : Google Scholar : PubMed/NCBI
27	Cheng YS, Chao J, Chen C, Lv LL, Han YC and Liu BC: The PKCβ-p66shc-NADPH oxidase pathway plays a crucial role in diabetic nephropathy. J Pharm Pharmacol. 71:338–347. 2019. View Article : Google Scholar : PubMed/NCBI
28	Haller M, Khalid S, Kremser L, Fresser F, Furlan T, Hermann M, Guenther J, Drasche A, Leitges M, Giorgio M, et al: Novel Insights into the PKCbeta-dependent Regulation of the Oxidoreductase p66Shc. J Biol Chem. 291:23557–23568. 2016. View Article : Google Scholar : PubMed/NCBI
29	Dragos D, Manea MM, Timofte D and Ionescu D: Mechanisms of herbal nephroprotection in diabetes mellitus. J Diabetes Res. 2020:57105132020. View Article : Google Scholar : PubMed/NCBI
30	Rayego-Mateos S, Morgado-Pascual JL, Opazo-Rios L, Guerrero-Hue M, Garcia-Caballero C, Vazquez-Carballo C, Mas S, Sanz AB, Herencia C, Mezzano S, et al: Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy. Int J Mol Sci. 21:37982020. View Article : Google Scholar
31	Davidson A, Berthier C and Kretzler M: Pathogenetic Mechanisms in lupus nephritis. Chapter 18. Dubois' Lupus Erythematosus and Related Syndromes. 8th edition. Wallace DJ and Hahn BH: W.B. Saunders; Philadelphia, PA: pp. 237–255. 2013, View Article : Google Scholar
32	Fu J, Wei C, Zhang W, Schlondorff D, Wu J, Cai M, He W, Baron MH, Chuang PY, Liu Z, et al: Gene expression profiles of glomerular endothelial cells support their role in the glomerulopathy of diabetic mice. Kidney Int. 94:326–345. 2018. View Article : Google Scholar : PubMed/NCBI
33	Wan C, Su H and Zhang C: Role of NADPH oxidase in metabolic disease-related renal injury: An update. Oxid Med Cell Longev. 2016:78130722016. View Article : Google Scholar : PubMed/NCBI
34	Chen X and Fang M: Oxidative stress mediated mitochondrial damage plays roles in pathogenesis of diabetic nephropathy rat. Eur Rev Med Pharmacol Sci. 22:5248–5254. 2018.PubMed/NCBI
35	Ebaid H, Bashandy SAE, Abdel-Mageed AM, Al-Tamimi J, Hassan I and Alhazza IM: Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress. Nutr Metab (Lond). 17:62020. View Article : Google Scholar : PubMed/NCBI
36	Xie Z, Zhong L, Wu Y, Wan X, Yang H, Xu X and Li P: Carnosic acid improves diabetic nephropathy by activating Nrf2/ARE and inhibition of NF-κB pathway. Phytomedicine. 47:161–173. 2018. View Article : Google Scholar : PubMed/NCBI
37	Orsini F, Migliaccio E, Moroni M, Contursi C, Raker VA, Piccini D, Martin-Padura I, Pelliccia G, Trinei M, Bono M, et al: The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J Biol Chem. 279:25689–25695. 2004. View Article : Google Scholar : PubMed/NCBI
38	DRUGDATAEXPY. 2009. Chongqing, . http://zy.yaozh.com/instruct/20160513-1/35.jpgMarch 1–2021
39	Nemoto S and Finkel T: Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science. 295:2450–2452. 2002. View Article : Google Scholar : PubMed/NCBI